Literature DB >> 16263814

Commentary: polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?

Jean-Patrice Baillargeon1, John E Nestler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16263814      PMCID： PMC3846532          DOI： 10.1210/jc.2005-1804

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  19 in total

1.  Inhibition of phosphatidylinositol 3-kinase enhances mitogenic actions of insulin in endothelial cells.

Authors:  Monica Montagnani; Inga Golovchenko; Injune Kim; Gou Young Koh; Marc L Goalstone; Ameya N Mundhekar; Mette Johansen; Dennis F Kucik; Michael J Quon; Boris Draznin
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

Review 2.  Insulin sensitizers for polycystic ovary syndrome.

Authors:  Jean-Patrice Baillargeon; Maria J Iuorno; John E Nestler
Journal:  Clin Obstet Gynecol       Date:  2003-06       Impact factor: 2.190

3.  A dual role of protein kinase C in insulin signal transduction via adenylyl cyclase signaling system in muscle tissues of vertebrates and invertebrates.

Authors:  S A Plesneva; A O Shpakov; L A Kuznetsova; M N Pertseva
Journal:  Biochem Pharmacol       Date:  2001-05-15       Impact factor: 5.858

4.  Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance.

Authors:  L Ciotta; A E Calogero; M Farina; V De Leo; A La Marca; A Cianci
Journal:  Hum Reprod       Date:  2001-10       Impact factor: 6.918

5.  Selective insulin resistance in the polycystic ovary syndrome.

Authors:  C B Book; A Dunaif
Journal:  J Clin Endocrinol Metab       Date:  1999-09       Impact factor: 5.958

Review 6.  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

Authors: 
Journal:  Hum Reprod       Date:  2004-01       Impact factor: 6.918

7.  Effects of metformin and rosiglitazone, alone and in combination, in nonobese women with polycystic ovary syndrome and normal indices of insulin sensitivity.

Authors:  Jean-Patrice Baillargeon; Daniela J Jakubowicz; Maria J Iuorno; Salomon Jakubowicz; John E Nestler
Journal:  Fertil Steril       Date:  2004-10       Impact factor: 7.329

8.  Insulin augmentation of 17alpha-hydroxylase activity is mediated by phosphatidyl inositol 3-kinase but not extracellular signal-regulated kinase-1/2 in human ovarian theca cells.

Authors:  Iqbal Munir; Hui-Wen Yen; David H Geller; Donna Torbati; Rebecca M Bierden; Stacy R Weitsman; Sanjay K Agarwal; Denis A Magoffin
Journal:  Endocrinology       Date:  2003-09-25       Impact factor: 4.736

9.  Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome.

Authors:  Xiao Ke Wu; Shan Ying Zhou; Jin Xia Liu; Pasi Pöllänen; Kirsimarja Sallinen; Marjaana Mäkinen; Risto Erkkola
Journal:  Fertil Steril       Date:  2003-10       Impact factor: 7.329

10.  Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome.

Authors:  J E Nestler; C O Barlascini; D W Matt; K A Steingold; S R Plymate; J N Clore; W G Blackard
Journal:  J Clin Endocrinol Metab       Date:  1989-06       Impact factor: 5.958
View more
  33 in total

1.  Suitability of recommended limits for fasting glucose tests in women with polycystic ovary syndrome.

Authors:  Claudia Gagnon; Jean-Patrice Baillargeon
Journal:  CMAJ       Date:  2007-03-27       Impact factor: 8.262

2.  Differential effects of insulin sensitivity on androgens in obese women with polycystic ovary syndrome or normal ovulation.

Authors:  Tomoko Asagami; Tyson H Holmes; Gerald Reaven
Journal:  Metabolism       Date:  2008-10       Impact factor: 8.694

Review 3.  Optimizing reproductive health in women with obesity and infertility.

Authors:  Matea Belan; Soren Harnois-Leblanc; Blandine Laferrère; Jean-Patrice Baillargeon
Journal:  CMAJ       Date:  2018-06-18       Impact factor: 8.262

4.  Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells.

Authors:  Sylvain Bellanger; Marie-Claude Battista; Guy D Fink; Jean-Patrice Baillargeon
Journal:  Steroids       Date:  2012-01-09       Impact factor: 2.668

Review 5.  Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.

Authors:  Daniel A Dumesic; Sharon E Oberfield; Elisabet Stener-Victorin; John C Marshall; Joop S Laven; Richard S Legro
Journal:  Endocr Rev       Date:  2015-10       Impact factor: 19.871

Review 6.  Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome.

Authors:  Elisabet Stener-Victorin; Vasantha Padmanabhan; Kirsty A Walters; Rebecca E Campbell; Anna Benrick; Paolo Giacobini; Daniel A Dumesic; David H Abbott
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

Review 7.  Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.

Authors:  Evanthia Diamanti-Kandarakis; Andrea Dunaif
Journal:  Endocr Rev       Date:  2012-10-12       Impact factor: 19.871

Review 8.  Genetics of the polycystic ovary syndrome.

Authors:  Gülüm Kosova; Margrit Urbanek
Journal:  Mol Cell Endocrinol       Date:  2012-10-16       Impact factor: 4.102

Review 9.  Ontogeny of the ovary in polycystic ovary syndrome.

Authors:  Daniel A Dumesic; Joanne S Richards
Journal:  Fertil Steril       Date:  2013-03-06       Impact factor: 7.329

10.  Uncoupling protein 2 expression affects androgen synthesis in polycystic ovary syndrome.

Authors:  Yun Liu; Hong Jiang; Fu-Qi Xing; Wu-Jian Huang; Li-Hua Mao; Ling-Yun He
Journal:  Endocrine       Date:  2012-09-25       Impact factor: 3.633
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.